1. Home
  2. SERA vs NUW Comparison

SERA vs NUW Comparison

Compare SERA & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SERA
  • NUW
  • Stock Information
  • Founded
  • SERA 2008
  • NUW 2008
  • Country
  • SERA United States
  • NUW United States
  • Employees
  • SERA N/A
  • NUW N/A
  • Industry
  • SERA Precision Instruments
  • NUW Investment Managers
  • Sector
  • SERA Health Care
  • NUW Finance
  • Exchange
  • SERA Nasdaq
  • NUW Nasdaq
  • Market Cap
  • SERA 258.3M
  • NUW 256.2M
  • IPO Year
  • SERA 2021
  • NUW N/A
  • Fundamental
  • Price
  • SERA $6.92
  • NUW $14.28
  • Analyst Decision
  • SERA
  • NUW
  • Analyst Count
  • SERA 0
  • NUW 0
  • Target Price
  • SERA N/A
  • NUW N/A
  • AVG Volume (30 Days)
  • SERA 140.4K
  • NUW 45.3K
  • Earning Date
  • SERA 11-06-2024
  • NUW 01-01-0001
  • Dividend Yield
  • SERA N/A
  • NUW 3.66%
  • EPS Growth
  • SERA N/A
  • NUW N/A
  • EPS
  • SERA N/A
  • NUW N/A
  • Revenue
  • SERA $107,000.00
  • NUW N/A
  • Revenue This Year
  • SERA N/A
  • NUW N/A
  • Revenue Next Year
  • SERA $2,020.00
  • NUW N/A
  • P/E Ratio
  • SERA N/A
  • NUW N/A
  • Revenue Growth
  • SERA N/A
  • NUW N/A
  • 52 Week Low
  • SERA $1.56
  • NUW $12.45
  • 52 Week High
  • SERA $12.36
  • NUW $14.44
  • Technical
  • Relative Strength Index (RSI)
  • SERA 42.37
  • NUW 58.19
  • Support Level
  • SERA $6.87
  • NUW $14.11
  • Resistance Level
  • SERA $8.19
  • NUW $14.38
  • Average True Range (ATR)
  • SERA 0.50
  • NUW 0.09
  • MACD
  • SERA -0.08
  • NUW -0.01
  • Stochastic Oscillator
  • SERA 3.68
  • NUW 62.96

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.

About NUW Nuveen AMT-Free Municipal Value Fund

Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations. The fund predominantly invests in long-term municipal bonds, corporate bonds, short-term municipal bonds, and other assets.

Share on Social Networks: